1 |
Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics-2019 update: a report from the American heart association[J]. Circulation, 2019, 139(10): e56-528.
|
2 |
Tibaut M, Mekis D, Petrovic D. Pathophysiology of myocardial infarction and acute management strategies[J]. Cardiovasc Hematol Agents Med Chem, 2017, 14(3): 150-9.
|
3 |
Dauerman HL, Ibanez B. The edge of time in acute myocardial infarction[J]. J Am Coll Cardiol, 2021, 77(15): 1871-4.
|
4 |
Thuny F, Lairez O, Roubille F, et al. Post-conditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarction[J]. J Am Coll Cardiol, 2012, 59(24): 2175-81.
|
5 |
Larose E, Rodés-Cabau J, Pibarot P, et al. Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardiovascular magnetic resonance[J]. J Am Coll Cardiol, 2010, 55(22): 2459-69.
|
6 |
Toldo S, Mauro AG, Cutter Z, et al. Inflammasome, pyroptosis, and cytokines in myocardial ischemia-reperfusion injury[J]. Am J Physiol Heart Circ Physiol, 2018, 315(6): H1553-68.
|
7 |
Zeng ZL, Li GH, Wu SY, et al. Role of pyroptosis in cardiovascular disease[J]. Cell Prolif, 2019, 52(2): e12563.
|
8 |
Zhang J, Huang L, Shi X, et al. Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway[J]. Aging: Albany NY, 2020, 12(23): 24270-87.
|
9 |
Liu S, Bi Y, Han T, et al. The E3 ubiquitin ligase MARCH2 protects against myocardial ischemia-reperfusion injury through inhibiting pyroptosis via negative regulation of PGAM5/MAVS/NLRP3 axis[J]. Cell Discov, 2024, 10(1): 24.
|
10 |
SWANSON K V, DENG M, TING J P. The NLRP3 inflammasome: molecular activation and regulation to therapeutics [J]. Nat Rev Immunol, 2019, 19(8): 477-89.
|
11 |
Bandopadhyay S, Mandal S, Ghorai M, et al. Therapeutic properties and pharmacological activities of asiaticoside and madecassoside: a review[J]. J Cell Mol Med, 2023, 27(5): 593-608.
|
12 |
阳 飞, 黄 辉, 王 芳, 等. 积雪草苷对大鼠心肌缺血再灌注损伤的保护作用以及MAPK通路的影响[J]. 中国医院药学杂志, 2021, 41(15): 1514-8. DOI: 10.13286/j.1001-5213.2021.15.06
|
13 |
卢国庆, 孙红燕, 孙正宇, 等. 积雪草苷对离体大鼠胸主动脉的舒张作用及其机制 [J]. 南方医科大学学报, 2024, 44(03): 523-32. DOI: 10.12122/j.issn.1673-4254.2024.03.14
|
14 |
Liu Y, Zhao JF, Mu XR, et al. Asiaticoside-nitric oxide promoting diabetic wound healing through the miRNA-21-5p/TGF-β1/SMAD7/TIMP3 signaling pathway[J]. J Ethnopharmacol, 2024, 319: 117266.
|
15 |
He ZL, Hu YY, Zhang Y, et al. Asiaticoside exerts neuroprotection through targeting NLRP3 inflammasome activation[J]. Phytomedicine, 2024, 127: 155494.
|
16 |
Li Y, Li Z, Liu J, et al. miR-190-5p alleviates myocardial ischemia-reperfusion injury by targeting PHLPP1[J]. Dis Markers, 2021, 2021: 8709298.
|
17 |
Pagliaro P, Penna C. Inhibitors of NLRP3 inflammasome in ischemic heart disease: focus on functional and redox aspects[J]. Antioxidants: Basel, 2023, 12(7): 1396.
|
18 |
Luan F, Rao ZL, Peng LX, et al. Cinnamic acid preserves against myocardial ischemia/reperfusion injury via suppression of NLRP3/Caspase-1/GSDMD signaling pathway[J]. Phytomedicine, 2022, 100: 154047.
|
19 |
Ahmad F, Marzook H, Gupta A, et al. GSK-3α aggravates inflammation, metabolic derangement, and cardiac injury post-ischemia/reperfusion[J]. J Mol Med, 2023, 101(11): 1379-96.
|
20 |
Peng LX, Lei ZQ, Rao ZL, et al. Cardioprotective activity of ethyl acetate extract of Cinnamomi Ramulus against myocardial ischemia/reperfusion injury in rats via inhibiting NLRP3 inflammasome activation and pyroptosis[J]. Phytomedicine, 2021, 93: 153798.
|
21 |
Shen SC, He F, Cheng C, et al. Uric acid aggravates myocardial ischemia–reperfusion injury via ROS/NLRP3 pyroptosis pathway[J]. Biomed Pharmacother, 2021, 133: 110990.
|
22 |
Wang Y, Liu X, Shi H, et al. NLRP3 inflammasome, an immune-inflammatory target in pathogenesis and treatment of cardiovascular diseases[J]. Clin Transl Med, 2020, 10(1): 91-106.
|
23 |
Blevins HM, Xu Y, Biby S, et al. The NLRP3 inflammasome pathway: a review of mechanisms and inhibitors for the treatment of inflammatory diseases[J]. Front Aging Neurosci, 2022, 14: 879021.
|
24 |
Chai X, Liang Z, Zhang J, et al. Chlorogenic acid protects against myocardial ischemia-reperfusion injury in mice by inhibiting Lnc Neat1/NLRP3 inflammasome-mediated pyroptosis[J]. Sci Rep, 2023, 13(1): 17803.
|
25 |
Li H, Yang DH, Zhang Y, et al. Geniposide suppresses NLRP3 inflammasome-mediated pyroptosis via the AMPK signaling pathway to mitigate myocardial ischemia/reperfusion injury[J]. Chin Med, 2022, 17(1): 73.
|
26 |
Xie DN, Guo HL, Li MB, et al. Splenic monocytes mediate inflammatory response and exacerbate myocardial ischemia/reperfusion injury in a mitochondrial cell-free DNA-TLR9-NLRP3-dependent fashion[J]. Basic Res Cardiol, 2023, 118(1): 44.
|
27 |
Bylka W, Znajdek-Awiżeń P, Studzińska-Sroka E, et al. Centella asiatica in cosmetology[J]. Postepy Dermatol Alergol, 2013, 30(1): 46-9.
|
28 |
He ZL, Hu YY, Niu ZQ, et al. A review of pharmacokinetic and pharmacological properties of asiaticoside, a major active constituent of Centella asiatica (L.) Urb[J]. J Ethnopharmacol, 2023, 302: 115865.
|
29 |
Ye CM, Yao ZC, Wang YY, et al. Asiaticoside promoted ferroptosis and suppressed immune escape in gastric cancer cells by down-regulating the Wnt/β‑catenin pathway[J]. Int Immunopharmacol, 2024, 134: 112175.
|
30 |
Liu X, Liu T, Yang K, et al. Antifatigue effect of asiaticoside in mice by attenuating oxidative stress[J]. Discov Med, 2023, 35(176): 275-82.
|
31 |
Liu K, Yin Y, Shi C, et al. Asiaticoside ameliorates DSS-induced colitis in mice by inhibiting inflammatory response, protecting intestinal barrier and regulating intestinal microecology[J]. Phytother Res, 2024, 38(4): 2023-40.
|
32 |
Zeng X, Yu J, Liu P, et al. Asiaticoside alleviates cardiomyocyte apoptosis and oxidative stress in myocardial ischemia/reperfusion injury via activating the PI3K-AKT-GSK3β pathway in vivo and in vitro [J]. Ann Transl Med, 2022, 10(2): 69.
|
33 |
Yao M, Wang J, Zhang J, et al. Asiaticoside attenuates oxygen-glucose deprivation/reoxygenation-caused injury of cardiomyocytes by inhibiting autophagy[J]. J Appl Toxicol, 2023, 43(6): 789-98.
|